The end of the historic Artemis II mission kicks off a race to establish a permanent human presence on the moon.
SEBI Grade A Phase 2 result: The Securities and Exchange Board of India (SEBI) has released the Grade A Phase 2 result 2026 on its official website, sebi.gov.in. Candidates who appeared for the Phase ...
The war in the Middle East that has knocked out liquefied natural gas facilities in Qatar has likely accelerated decision-making for LNG Canada’s Phase 2 expansion at Kitimat, analysts believe, even ...
A Metropolitan Transportation Authority rendering shows a conceptual interior of a future Second Avenue Subway station in Harlem, illustrating platform circulation, train clearances and passenger flow ...
Michael Block is a 14 time GLAM Award nominated writer, producer, and host of the podcast Block Talk. Throughout his time in the entertainment industry, he has worked on and off Broadway as a stage ...
More antibodies take aim at seeded propagation. New data ties tangle location to deficits in specific cognitive domains. Three first-in-human studies for antibodies targeting different parts of tau ...
Kelluu produces hydrogen-powered airships, providing aerial sensing capability as a service. Above, testing during NATO ‘REPMUS 2025'. (NATO DIANA) NATO's Defence Innovation Accelerator for the North ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel GLP-1 and amylin receptor agonist reduced HbA1c ...
Woodside’s top executive is very bullish about a second development phase on its flagship Sangomar deepwater project offshore Senegal, which is could involve a potential 30-well subsea system.
AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a phase 2 study. The U.K.-based pharma had been evaluating the antisense ...
FDA lifts clinical hold following review of Company’s Complete Response submission. Company expects to restart U.S. enrollment in late 2025 or early 2026 across 20 clinical sites. Early data suggests ...